Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006

Pediatric Infectious Disease Journal

Volumn 29, Issue 8, 2010, Pages 685-689

  Nguyen, Michael D ^a,b   Perella, Dana ^b   Watson, Barbara ^b   Marin, Mona ^c   Renwick, Mia ^a   Spain, C Victor ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

vaccine effectiveness; varicella outbreak; varicella vaccination

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; CHICKENPOX; CHILD; DRUG EFFICACY; EPIDEMIC; HUMAN; INFECTION CONTROL; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; UNITED STATES; VACCINATION; FEMALE; IMMUNIZATION; IMMUNOLOGY; INCIDENCE; MALE; PROCEDURES; SCHOOL; TREATMENT OUTCOME;

CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; MALE; PHILADELPHIA; QUESTIONNAIRES; SCHOOLS; TREATMENT OUTCOME;

EID: 77955174872     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181d9f657     Document Type: Article

References (28)

1. Seward J, Watson B, Peterson C, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287: 606-611.
2. Guris D, Jumaan A, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis. 2008; 197(suppl 2):S71-S75.
3. Reynolds M, Watson B, Plott-Adams K, et al. Epidemiology of varicella hospitalizations in the United States, 1995-2005. J Infect Dis. 2008; 197(suppl 2):S120-S126.
4. Marin M, Jumaan A, Zhang J, Seward J. A decade of varicella prevention in the United States: successes and challenges. International Herpesvirus Workshop, Esturil Portugal, 2008.
5. Centers for Disease Control and Prevention. Outbreak of varicella among vaccinated children-Michigan 2003. MMWR. 2004 53 389-392.
6. Lopez A, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose. Pediatrics. 2006;117:e1070-e1077.
7. Parker AA, Reynolds MA, Leung J, et al. Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement-Maine, 2006. J Infect Dis. 2008; 197(suppl 2):S101-S107.
8. Tugwell BD, Lee LE, Gillette H, et al. Chickenpox outbreak in a highly vaccinated school population. Pediatrics. 2004;113:455-459
9. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2007;56(RR-4):1-40.
10. Hall S, Galil K, Watson BM, Seward J. The use of school-based vaccination clinics to control varicella outbreaks in two schools. Pediatrics. 2000;105:e17.
11. Loparev V, McCaustland K, Holloway B, et al. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol. 2000;38:4315-4319.
12. Loparev VN, Argaw T, Krause PR, et al. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol. 2000;38:3156-3160.
13. Council of State and Territorial Epidemiologists. Position Statement 99-ID-9. Vaccine preventable disease: surveillance and reporting. CSTE, 1999. Available at http://www.cste.org/ps/1999/1999-id-09.htm.
14. Watson B, Rothstein E, Bernstein H, et al. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization. J Infect Dis. 1995;172:217-219.
15. Pichichero M, Voloshen T, Passador S. Kinetics of booster responses to haemophilus influenzae type B conjugate after combined diptheria- tetanusacellcular Pertussis haemophilus influenzae type B vaccination in infants. Pediatr Infect Dis J. 1999;18:1106-1108.
16. Strebel PM, Dayan GH, Halsey NA. Measles vaccine. In: Plotkin S, Orenstein WA, Offit PA, eds. Vaccines. Saunders: Elsevier; 2008:353-398.
17. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008:29-46.
18. Allison P. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute Inc; 1995.
19. Kleinbaum D, Kupper L, Muller K, Nizam A. Applied Regression Analysis and Other Multivariable Methods, 3rd ed. Pacific Grove, CA: Suxbury Press; 1998.
20. Orenstein W, Bernier R, Hinman A. Assessing vaccine efficacy in the field: further observations. Epidemiol Rev. 1988;10:212-241.
21. Hosmer D, Lemeshow S. Applied Survival Analysis. New York: John Wiley & Sons; 1999.
22. Gould PL, Leung J, Scott C, Schmid DS, Deng H, Lopez A, Chaves SS, Reynolds M, Gladden L, Harpaz R, Snow S. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients-Arkansas, 2006. Pediatr Infect Dis J. 2009;28:678-681.
23. Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008 Mar 1;197(Suppl 2): S82-S89
24. National Vaccine Advisory Committee. Standards for child and adolescent immunization practices. Pediatrics. 2003;112:958-963.
25. Plotkin S, Orenstein WA, Offit PA. Vaccines, 5th ed: Saunders: Elsevier; 2008.
26. Chaves SS, Haber P, Walton K, et al. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis. 2008;197(suppl 2): S170-S177.
27. Galea SA, Sweet A, Beninger P, et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis. 2008;197(suppl 2):S165-S169.
28. Ngai AL, Staehle BO, Kuter BJ, et al. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J. 1996;15:49-54.